The assay of phenylbutazone in human plasma by a specific and sensitive gas-liquid chromatographic procedure.
作者信息
McGilveray I J, Midha K K, Brien R, Wilson L
出版信息
J Chromatogr. 1974 Feb 13;89(1):17-22. doi: 10.1016/s0021-9673(01)84154-6.
PMID:4815964
Abstract
摘要
相似文献
1
The assay of phenylbutazone in human plasma by a specific and sensitive gas-liquid chromatographic procedure.采用一种特异且灵敏的气液色谱法测定人血浆中的保泰松。
J Chromatogr. 1974 Feb 13;89(1):17-22. doi: 10.1016/s0021-9673(01)84154-6.
2
Simultaneous determination of phenylbutazone and oxyphenbutazone in plasma by high-speed liquid chromatography.
J Pharm Sci. 1975 Feb;64(2):284-7. doi: 10.1002/jps.2600640219.
3
Oxyphenbutazone and phenylbutazone determination in plasma and urine by GLC.采用气相色谱法测定血浆和尿液中的羟苯丁酮和保泰松。
J Pharm Sci. 1974 Mar;63(3):446-8. doi: 10.1002/jps.2600630331.
4
Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.高效液相色谱法同时测定血浆和尿液中保泰松及其代谢产物
J Chromatogr. 1980 Sep 12;183(3):331-8. doi: 10.1016/s0378-4347(00)81713-2.
5
GLC determination of plasma concentration of phenylbutazone and its metabolite oxyphenbutazone.用气相色谱法测定保泰松及其代谢物羟基保泰松的血浆浓度。
J Pharm Sci. 1974 Aug;63(8):1234-9. doi: 10.1002/jps.2600630814.
6
Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
J Chromatogr. 1992 Oct 2;581(1):101-7. doi: 10.1016/0378-4347(92)80452-v.
7
A supercritical fluid chromatographic method using packed columns for phenylbutazone and oxyphenbutazone in serum, and for phenylbutazone in a dosage form.
J Pharm Biomed Anal. 1995 Jan;13(1):59-64. doi: 10.1016/0731-7085(95)90652-k.
8
[Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
Arzneimittelforschung. 1981;31(3):495-9.
9
Separation of furosemide, phenylbutazone and oxyphenbutazone in plasma by direct injection onto internal surface reversed-phase columns with systematic optimization of selectivity.通过直接进样到内表面反相柱上并对选择性进行系统优化，实现血浆中呋塞米、保泰松和羟布宗的分离。
J Chromatogr. 1986 Oct 3;367(2):412-8. doi: 10.1016/s0021-9673(00)94862-3.
10
Screening, quantification, and confirmation of phenylbutazone and oxyphenbutazone in equine plasma by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法对马血浆中的保泰松和羟基保泰松进行筛查、定量和确证。
J Anal Toxicol. 2009 Jan-Feb;33(1):41-50. doi: 10.1093/jat/33.1.41.
引用本文的文献
1
Specimen handling in an HPLC determination of phenylbutazone and its major metabolites in plasma, avoiding degradation of the compounds.
Pharm Weekbl Sci. 1986 Aug 22;8(4):229-33. doi: 10.1007/BF01957783.
2
Clinical pharmacokinetics of phenylbutazone.保泰松的临床药代动力学
Clin Pharmacokinet. 1978 Sep-Oct;3(5):369-80. doi: 10.2165/00003088-197803050-00003.
Zotero 插件